Essex Financial Services Inc. Buys 766 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Essex Financial Services Inc. grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.5% in the fourth quarter, Holdings Channel reports. The fund owned 8,818 shares of the company’s stock after acquiring an additional 766 shares during the quarter. Essex Financial Services Inc.’s holdings in GE HealthCare Technologies were worth $689,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. CWM LLC increased its holdings in GE HealthCare Technologies by 5.0% in the 3rd quarter. CWM LLC now owns 11,186 shares of the company’s stock worth $1,050,000 after acquiring an additional 531 shares during the last quarter. Exchange Traded Concepts LLC boosted its position in GE HealthCare Technologies by 1.7% during the third quarter. Exchange Traded Concepts LLC now owns 10,676 shares of the company’s stock worth $1,002,000 after purchasing an additional 175 shares during the period. Wesbanco Bank Inc. increased its stake in shares of GE HealthCare Technologies by 14.6% in the third quarter. Wesbanco Bank Inc. now owns 17,027 shares of the company’s stock worth $1,598,000 after purchasing an additional 2,175 shares in the last quarter. Swedbank AB raised its position in shares of GE HealthCare Technologies by 6.6% in the third quarter. Swedbank AB now owns 72,013 shares of the company’s stock valued at $6,758,000 after purchasing an additional 4,490 shares during the period. Finally, Vontobel Holding Ltd. lifted its stake in shares of GE HealthCare Technologies by 71.0% during the 3rd quarter. Vontobel Holding Ltd. now owns 41,294 shares of the company’s stock valued at $3,875,000 after buying an additional 17,145 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

GEHC has been the subject of a number of recent research reports. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus target price of $96.77.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $85.90 on Thursday. The stock’s 50-day simple moving average is $83.58 and its two-hundred day simple moving average is $85.39. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.55. The firm has a market capitalization of $39.25 billion, a P/E ratio of 23.60, a P/E/G ratio of 2.93 and a beta of 1.15. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio is 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.